1-benzyloxycarbonyl-4-(1-(4-methoxyphenyl)-5-(4-tolyl)-1H-pyrazol-3-yl)piperidine 在
氢气 作用下,
以
甲醇 为溶剂,
反应 2.0h,
以to give a title compound (577 mg, 1.7 mmol, quant.) as a light yellow amorphous product的产率得到4-(1-(4-methoxyphenyl)-5-(4-tolyl)-1H-pyrazol-3-yl)piperidine
参考文献:
名称:
UREIDE DERIVATIVE AND PHARMACEUTICAL APPLICATION THEREOF
UREIDE DERIVATIVE AND USE THEREOF FOR MEDICAL PURPOSES
申请人:TORAY INDUSTRIES, INC.
公开号:EP2009006A1
公开(公告)日:2008-12-31
This invention relates to a pharmaceutical comprising, as an active ingredient, a ureide derivative represented by formula:
or a pharmaceutically acceptable salt thereof. The ureide derivative or a pharmaceutically acceptable salt thereof according to the present invention is useful for relieving pain and treating or preventing neuropathic pain.
UREIDE DERIVATIVE AND PHARMACEUTICAL APPLICATION THEREOF
申请人:Sugawara Yuji
公开号:US20100234395A1
公开(公告)日:2010-09-16
Discloses is a pharmaceutical agent comprising an ureide derivative represented by the formula: or a pharmaceutically acceptable salt thereof as an active ingredient. The ureide derivative or the pharmaceutically acceptable salt thereof is useful for the relief of a pain or the treatment or prevention of neurogenic pain.